Clinical Varieties of Neuromuscular Disease in Debrancher Deficiency

Archives of Neurology

Volumn 41, Issue 10, 1984, Pages 1027-1032

  Cornelio, Ferdinando ^a   Bresolin, Nereo ^b   Singer, Philip A ^c   Dimauro, Salvatore ^b   Rowland, Lewis P ^b  

^a Istituto Neurologico   (Italy)

^b Department of Orthopaedic Surgery   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASE REPORT; DIAGNOSIS; ELECTROMYOGRAPHY; ELECTRON MICROSCOPY; ETIOLOGY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MOTOR NEURON DISEASE; MUSCLE; MUSCLE BIOPSY; NERVE CONDUCTION; NERVOUS SYSTEM; NEUROMUSCULAR DISEASE; PERIPHERAL NERVOUS SYSTEM;

ADULT; FEMALE; GLYCOGEN STORAGE DISEASE; GLYCOGEN STORAGE DISEASE TYPE III; HUMANS; MALE; MIDDLE AGED; MUSCULAR DISEASES;

EID: 0021219367     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1984.04050210025008     Document Type: Article

References (33)

1. 1. Howell RR: The glycogen storage disease, in Stanbury JB, Wyngaarden JB, Fredrickson DS (eds): The Metabolic Basis of Inherited Disease. New York, McGraw-Hill Book Co, 1978, pp 137-159.
2. 2. DiMauro S: Metabolic myopathies, in Vinken PJ, Bruyn FW, (eds): Handbook of Clinical Neurology. Amsterdam, North-Holland Publishing Co, 1980, vol 41: Diseases of Muscle, pt 2, pp 175-234.
3. 3. DiMauro S, Hartwig GB, Hays A, et al: Debrancher deficiency: Neuromuscular disorder in five adults. Ann Neurol 1979;5:422-436.
4. 4. Neustein HB: Fine structure of skeletal muscle in type III glycogenosis. Arch Pathol Lab Med 1969;88:130-136.
5. 5. Dreyfus JC: Les glycogenoses musculaires. Ann Anat Pathol 1973;18:169-194.
6. 6. Oliner L, Schulman M, Larner J: Myopathy associated with glycogen deposition resulting from generalized lack of amyo-1,6-glucosidase, abstracted. Clin Res 1961;9:243.
7. 7. Brunberg JA, McCormick WF, Schochet SS Jr: Type III glycogenosis: An adult with diffuse weakness and muscle wasting. Arch Neurol 1971; 25:171-178.
8. 8. Broker HJ, Kuhn E, Fiehn W, et al: Glykogenose durch Amylo-1,6-glucosidase-Mangel. Schweiz Med Wochenschr 1981;111:854-858.
9. 9. Osame M, Iwamasa T, Fukunaga H, et al: Debrancher deficiency myopathy: Three adults including two siblings, Proc Ann Meet Muse Res Group 1980, pp 48-49.
10. 10. Ozand P, Tokatli M, Amiri S: Biochemical investigation of an unusual case of glycogenosis. J Pediatr 1967;71:225-232.
11. 11. Murase T, Ikeda H, Muro T, et al: Myopathy associated with type III glycogenosis. J Neurol Sci 1973;20:287-295.
12. 12. Badurska G, Fidzianska A, Kwiatkowska Z: Muscular glycogenosis type III in a 15-year-old boy. Neuropatol Pol 1970;8:265-270.
13. 13. Pellissier JF, de Barsy T, Faugere MC, et al: Type III glycogenosis with multicore structures. Muscle Nerve 1979;2:124-132.
14. 14. Rossignol AM, Meyer M, Rossignol B, et al: La myocardiopathie de la glycogenose type III. Arch Fr Pediatr 1979;36:303-309.
15. 15. Slonim AG, Weisberg C, Benke P, et al: Reversal of debrancher deficiency myopathy by the use of high-protein nutrition. Ann Neurol 1982;11:420-422.
16. 16. DiMauro S, Miranda AF, Khan S, et al: Human muscle phosphoglycerate mutase deficiency: Newly discovered metabolic myopathy. Science 1981;212:1277-1279.
17. 17. DiMauro S, Miranda AF, Olarte M, et al: Muscle phosphoglycerate mutase deficiency. Neurology 1982;32:584-591.
18. 18. Bresolin N, Ro YI, Reyes M, et al: Muscle phosphoglycerate mutase (PGAM) deficiency: A second case. Neurology 1983;33:1049-1052.
19. 19. Kanno T, Sudo K, Takeuchi I, et al: Hereditary deficiency of lactate dehydrogenase M subunit. Clin Chim Acta 1980;108:267-276.
20. 20. DiMauro S, Bresolin N, Hays AP: Disorders of glycogen metabolism of muscle. CRC Crit Rev Clin Neurobiol 1984;1:1-34.
21. 21. Corbett AJ, Griggs RC, Moxley RT: Skeletal muscle catabolism in amyotrophic lateral sclerosis and chronic spinal muscular atrophy. Neurology 1982;32:550-552.
22. 22. Illingworth B: Glycogen storage disease. Am J Clin Nutr 1961;9:683-690.
23. 23. Sidbury JB, Cornblath M, Fisher J, et al: Glycogen in erythrocytes of patients with glycogen storage disease. Pediatrics 1961;27:103-111.
24. 24. Chayoth R, Moses SW, Steinitz K: Debrancher enzyme activity in blood cells of families with type III glycogen storage disease. Isr J Med Sci 1967;3:422-426.
25. 25. Van Hoof F: Amylo-1,6-glucosidase activity and glycogen content of the erythrocytes of normal subjects, patients with glycogen-storage disease and heterozygotes. Eur J Biochem 1967; 2:271-274.
26. 26. Moses SW, Chayoth R, Levin S, et al: Glucose and glycogen metabolism in erythrocytes from normal and glycogen storage type III subjects. J Clin Invest 1968;47:1343-1348.
27. 27. Steinitz K, Bodur H, Arman T: Amylo-1,6-glucosidase activity in leukocytes from patients with glycogen storage diseases. Clin Chim Acta 1963;8:807-809.
28. 28. Williams HE, Kendig EM, Field JB: Leukocytes debranching enzyme in glycogen storage disease. J Clin Invest 1963;42:656-660.
29. 29. Huijing F: Amylo-1,6-glucosidase activity in normal leucocytes and leucocytes of patients with glycogen storage disease. Clin Chim Acta 1964;9:269-272.
30. 30. Garancis JC, Panares RP, Good TA, et al: Type III glycogenosis: A biochemical and electron microscopic study. Lab Invest 1970;22:468-477.
31. 31. Justice P, Ryan C, Hsia DYY, et al: Amylo-1,6-glucosidase in human fibroblasts: Studies in type III glycogen storage disease. Biochem Biophys Res Commun 1970;39:135-141.
32. 32. Miranda AF, DiMauro S, Antler A, et al: Glycogen debrancher deficiency is reproduced in muscle culture. Ann Neurol 1981;9:283-288.
33. 33. Hug G, Schubert WK: Glycogenosis associated with degenerative disease of the brain: Biochemical and electron microscopic findings, abstracted. Clin Res 1966;14:441.